Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Elowsson, A. Lofdahl (anna.lofdahl@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), O. Rosmark (oskar.rosmark@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), C. Muller (catharina.muller@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), A. Larsson Callerfelt (anna-karin.larsson_callerfelt@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), J. Malmstrom (johan.malmstrom@med.lu.se / Division of Infection Medicine, C. Sciences, L. University,Lund), E. Ahrman (emma.ahrman@med.lu.se / Division of Infection Medicine, C. Sciences, L. University,Lund), G. Westergren-Thorsson (gunilla.westergren-thorsson@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund). LSC - 2018 - Material properties of lung scaffolds derived from healthy and IPF donor tissues are associated with disease pathology. 987

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung. Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 YI401 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung Source: ERS Lung Science Conference 2021 Year: 2021 Late Breaking Abstract - Repopulated healthy and IPF lung scaffolds show temporal differences in ECM turnover Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 LSC - 2018 - Physical and biochemical interactions drive fibrocytes accumulation in the scleroderma lung matrix Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Analysis of the lung microbiota in healthy dogs and in canine idiopathic pulmonary fibrosis, a possible spontaneous model for human IPF. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 The prevalence of neoplastic transformation in idiopathic pulmonary fibrosis (IPF) lungs. A report from a transplanted IPF population Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 mRNA expression of YY1, TNF-α a TGF-β in lung samples gained by transbronchial biopsies (TBB) in patients with different interstitial lung diseases (ILDs) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 WFDC2 (HE4) and SLPI are differentially expressed in normal and diseased human lung and in lung cancer Source: Annual Congress 2006 - Molecular airway biology Year: 2006 LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Human lung scaffolds to model lung disease and tissue regeneration Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration Year: 2018 Late Breaking Abstract - Nano-mechanical properties of bronchial wall biopsies as a potential remodeling marker in obstructive lung disease - preliminary findings. Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Two new NKX2-1 mutations associated with pediatric interstitial lung diseases Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Comparison of different field tests for functional capacity assessment in individuals with fibrosing interstitial lung disease. Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002 T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation Source: International Congress 2016 – Mechanisms of disease Year: 2016 Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015